Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/1998
09/11/1998WO1998039659A1 Screening and treatment using complement regulator or receptor proteins
09/11/1998WO1998039463A2 Lentivirus based vector and vector system
09/11/1998WO1998039451A1 Feline immunodeficiency virus clone jsy3
09/11/1998WO1998039450A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS
09/11/1998WO1998039441A1 Human chemokine receptor-like chemokine
09/11/1998WO1998039434A1 Methods and reagents for modulating apoptosis
09/11/1998WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer
09/11/1998WO1998039428A1 Method for inducing mutations and the use thereof in the production of a vaccine against pathogenic microorganisms
09/11/1998WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
09/11/1998WO1998039363A2 Immunotoxins and methods of inducing immune tolerance
09/11/1998WO1998039360A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection
09/11/1998WO1998039037A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
09/11/1998WO1998039034A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
09/11/1998WO1998039033A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein
09/11/1998WO1998039032A1 Immunopotentiating formulations for vaccinal use
09/11/1998WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
09/11/1998WO1998039030A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998WO1998039029A2 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
09/11/1998WO1998039028A1 Lyme combination compositions and uses
09/11/1998WO1998039027A2 Sialyl lewis antigens as targets for immunotherapy
09/11/1998WO1998039025A2 A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease
09/11/1998WO1998039016A1 Immune tolerance inducers
09/11/1998WO1998031712A3 Chitosan-conjugates with acidic chelate-complex forming agents
09/11/1998WO1998031393A3 Polysaccharide-peptide-conjugates
09/11/1998WO1998030707A3 Eukaryotic gene expression cassette and uses thereof
09/11/1998WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
09/11/1998WO1998027110A3 Dihydroxypropyl cysteine peptide and agent containing this peptide
09/11/1998WO1998025956A3 Human GTP-binding proteins
09/11/1998WO1998024912A3 Recombinant plague vaccine
09/11/1998WO1998016238A3 Cancer immunotherapy using tumor cells combined with mixed lymphocytes
09/11/1998CA2284083A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection
09/11/1998CA2283394A1 Methods and compositions for diagnosis and treatment of cancer
09/11/1998CA2283344A1 Immunopotentiating formulations for vaccinal use
09/11/1998CA2283300A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein
09/11/1998CA2283143A1 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
09/11/1998CA2283076A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998CA2282760A1 Human chemokine receptor-like chemokine
09/11/1998CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
09/11/1998CA2281934A1 Use of preparations containing anti-cd44 antibodies for the treatment of certain tumours and for the supression of immune reactions
09/10/1998DE19709512A1 Recombinant influenza virus
09/10/1998DE19708537A1 Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc. New surface protein (SpsA protein) of Streptococcus pneumoniae, etc.
09/10/1998CA2231591A1 Bovine respiratory coronavirus
09/09/1998EP0863211A1 Expression of recombinant fusion proteins in attenuated bacteria
09/09/1998EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof
09/09/1998EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus
09/09/1998EP0863155A1 Suppression of T-cell proliferation using peptide fragments of myelin basic protein
09/09/1998EP0863152A2 Streptococcus pneumoniae Def1 protein
09/09/1998EP0863151A1 "Canine parvovirus dna vaccines"
09/09/1998EP0862919A1 Remedy for hepatitides
09/09/1998EP0862740A1 Oncogene fusion protein peptide vaccines
09/09/1998EP0862634A1 Pharmaceutical composition for treating papillomavirus tumours and infection
09/09/1998EP0862633A1 Virus protein antigens of the jc virus
09/09/1998EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
09/09/1998EP0862615A1 Immunity against pasteurella haemolytica leukotoxin
09/09/1998EP0862584A1 Production of antibodies, and medical uses involving antibodies
09/09/1998EP0862461A1 Methods of treating established colitis using antibodies against il-12
09/09/1998EP0862460A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling
09/09/1998EP0862447A1 Generating d-peptides: methods and compositions
09/09/1998EP0862419A1 Microencapsulated dna for vaccination and gene therapy
09/09/1998EP0650498B1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
09/09/1998EP0573527B1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
09/09/1998CN1192783A Marek's disease virus genes and their use in vaccines for protection against marek's disease
09/09/1998CN1192779A Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions
09/09/1998CN1192751A Monocype chemotactic protein-4
09/09/1998CN1192695A High affinity human monoclonal antibodies specific for RSV F-protein
09/09/1998CN1192694A Vector for diagnosis and treatment of solid tumors including melanoma
09/09/1998CN1192693A Therapeutic agent and autoimmune diseases
09/09/1998CN1192692A Inhibin compositions and method of enhancing production performance
09/08/1998US5804566 Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
09/08/1998US5804561 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
09/08/1998US5804440 A deoxypolynucleotide encoding heavy chanin immunologlobulin variable region amino acid residue sequence portion of humans monoclonal antibody which is used in immunotherapy and diagnosis
09/08/1998US5804430 Bovine ovary cell line (FROV) for virus replication
09/08/1998US5804413 Herpes simplex virus strains for gene transfer
09/08/1998US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase
09/08/1998US5804381 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
09/08/1998US5804372 Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus
09/08/1998US5804201 Immunomodulatory peptides of vespid antigen 5
09/08/1998US5804200 Parasitic nematode proteins and vaccines
09/08/1998US5804199 Oil-based and water-based adjuvant mixture
09/08/1998US5804198 Vaccines against disease caused by pathogenic pilus-forming bacteria
09/08/1998US5804197 Recombinant canine herpesviruses
09/08/1998US5804196 Self assembled, defective, nonself-propagating viral particles
09/08/1998US5804195 Vaccine comprising an infectious bursal disease virus MB, MB-1 or MB-2 strain
09/08/1998US5804194 Immunophrophylaxis by deletion of a gene encoding a protein produced in response to environmental stress; treatment of food poisoning, typhoid, salmonellosis in pigs
09/08/1998US5804193 Pneumococcal surface protein a; immunoprotective; vaccines
09/08/1998US5804190 Recombinant vaccine for porcine pleuropneumonia
09/03/1998WO1998038320A1 Component of bromelain
09/03/1998WO1998038319A1 Component of bromelain
09/03/1998WO1998038312A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
09/03/1998WO1998038310A1 A tm4sf human tumor-associated antigen
09/03/1998WO1998038307A1 Novel human transmembrane 4 superfamily protein
09/03/1998WO1998038305A1 Physiologically active protein originating in mammals
09/03/1998WO1998038291A1 Component of bromelain
09/03/1998WO1998038216A1 Cell surface molecule mediating cell adhesion and signal transmission
09/03/1998WO1998038212A2 Chimeric polypeptides containing chemokine domains
09/03/1998WO1998037918A1 Staphylococcus 3-dehydroquinate synthase
09/03/1998WO1998037917A1 Novel processes implementing selective immune down regulation (sidr)
09/03/1998WO1998037916A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
09/03/1998WO1998037912A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method
09/03/1998WO1998037911A1 Chimeric flavivirus vaccines
1 ... 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 ... 1823